Emeis stock loses its last support at €9.89 and declines 3%
The operator of elderly care facilities is accelerating its slide mid-morning, in a Paris market clearly oriented downwards. The stock loses a technical threshold that had served as a last bastion for several weeks.
The Emeis stock declines 3.23% to €9.59 in trading, while the SBF 120 retreats 1.49%. The price has broken through the €9.89 threshold, which corresponded to both the lows of the last 30, 150 and 250 trading sessions: there is no longer any identified support below the current level, and this threshold now becomes a resistance. The RSI at 25 reflects the extent of a 21.13% decline over one month.
The stock is meanwhile trading nearly 30% below its 200-day moving average, situated at €13.62. This decline extends that of previous sessions: on October 19, the stock was already declining 3.5% near this same level.
Third quarter activity update expected on October 29
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The group will publish its third quarter 2026 activity update on October 29. During the H1 2026 results, published on July 29, management indicated that first half performance allowed for an upward revision of its 2026 guidance, with the trend observed since the beginning of the year exceeding its initial expectations. This publication comes in a context of tension on French rates: the 10-year OAT stands at 4.99% according to the Bank of France report of October 21, its highest level since 2004 for the series being tracked. As for the underlying trend, the stock declines 30.91% over three months.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3 011 millions d'euros
Quarterly revenue: 3 011 millions d'euros
EBITDA: 461 millions d'euros
EBITDA margin: 15,3 %
Net income: -40,4 millions d'euros
Free cash flow: -153 millions d'euros
3 862 millions d'euros
Guidance from the release
First-half performance allows for an upward revision of the 2026 guidance; the trend since the start of the year confirms the continued momentum observed in 2025 and even shows performance that exceeded the Group's initial expectations
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
